R J G Chalmers

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. ncbi Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?
    Rorert Chalmers
    Dermatology Centre, Hope Hospital, Salford, Manchester
    Clin Med 5:230-4. 2005
  2. ncbi Methotrexate for psoriasis in the era of biological therapy
    R B Warren
    Department of Dermatological Sciences, Salford Royal Hospital, University of Manchester, Manchester, UK
    Clin Exp Dermatol 33:551-4. 2008
  3. ncbi Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis
    R J G Chalmers
    Dermatology Centre, University of Manchester, Hope Hospital, Salford, Manchester M6 8HD, UK
    Br J Dermatol 152:444-50. 2005
  4. ncbi Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study
    V Madan
    The Dermatology Centre, Salford Royal Hospitals NHS Foundation Trust, Salford, UK
    Clin Exp Dermatol 35:27-30. 2010
  5. ncbi A classification of psoriasis vulgaris according to phenotype
    C E M Griffiths
    Dermatology Centre, The University of Manchester, Hope Hospital, Salford, Manchester, UK
    Br J Dermatol 156:258-62. 2007
  6. ncbi Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab
    C L Reddick
    The Dermatology Centre, University of Manchester, Salford Royal Foundation Hospital, Manchester, United Kingdom
    Dermatol Online J 16:15. 2010
  7. ncbi Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases
    M J Harries
    The Dermatology Centre, The University of Manchester, Hope Hospital, Stott Lane, Salford, Manchester, UK
    Br J Dermatol 153:549-51. 2005
  8. ncbi The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial
    C E M Griffiths
    Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Br J Dermatol 155:393-400. 2006
  9. ncbi Inpatient management of psoriasis: a multicentre service review to establish national admission standards
    A L Woods
    Skin Therapy Research Unit, St John s Institute of Dermatology, St Thomas Hospital, and Imperial College, London SE1 9RT, UK
    Br J Dermatol 158:266-72. 2008
  10. ncbi British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005
    C H Smith
    St John's Institute of Dermatology, GKT School of Medicine, St Thomas' Hospital, London SE1 7EH, UK
    Br J Dermatol 153:486-97. 2005

Detail Information

Publications12

  1. ncbi Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?
    Rorert Chalmers
    Dermatology Centre, Hope Hospital, Salford, Manchester
    Clin Med 5:230-4. 2005
    ..The NHS needs to listen to its users, ie the patients, and to its clinical staff, and to encourage them to engage in research to help reduce those uncertainties...
  2. ncbi Methotrexate for psoriasis in the era of biological therapy
    R B Warren
    Department of Dermatological Sciences, Salford Royal Hospital, University of Manchester, Manchester, UK
    Clin Exp Dermatol 33:551-4. 2008
    ..Furthermore, the potential for personalized methotrexate use by application of modern pharmacogenetics and pharmacokinetics may ensure its place as a first-line agent for the treatment of psoriasis for the foreseeable future...
  3. ncbi Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis
    R J G Chalmers
    Dermatology Centre, University of Manchester, Hope Hospital, Salford, Manchester M6 8HD, UK
    Br J Dermatol 152:444-50. 2005
    ..More recently, monitoring by serum procollagen III aminopeptide (PIIINP) measurement (Orion Diagnostica, Espoo, Finland) has been advocated as a means of significantly reducing the need for liver biopsy...
  4. ncbi Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study
    V Madan
    The Dermatology Centre, Salford Royal Hospitals NHS Foundation Trust, Salford, UK
    Clin Exp Dermatol 35:27-30. 2010
    ..Objectives. To evaluate the efficacy of a specially formulated preparation of tacrolimus 0.3% in clobetasol propionate 0.05% ointment (TCPO) in the treatment of CLE...
  5. ncbi A classification of psoriasis vulgaris according to phenotype
    C E M Griffiths
    Dermatology Centre, The University of Manchester, Hope Hospital, Salford, Manchester, UK
    Br J Dermatol 156:258-62. 2007
    ..A meeting of the International Psoriasis Council produced a consensus on clinical phenotypes of psoriasis equally relevant to clinical practitioners and psoriasis researchers...
  6. ncbi Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab
    C L Reddick
    The Dermatology Centre, University of Manchester, Salford Royal Foundation Hospital, Manchester, United Kingdom
    Dermatol Online J 16:15. 2010
    ..To date, there is less evidence about the use of adalimumab for these conditions. We report a patient with severe superficial PG on a background of HS, which responded to adalumimab therapy after failure of infliximab therapy...
  7. ncbi Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases
    M J Harries
    The Dermatology Centre, The University of Manchester, Hope Hospital, Stott Lane, Salford, Manchester, UK
    Br J Dermatol 153:549-51. 2005
    ..A recent systematic review has shown FAE to be an effective systemic treatment for severe psoriasis. However, FAE remain unlicensed in the U.K...
  8. ncbi The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial
    C E M Griffiths
    Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Br J Dermatol 155:393-400. 2006
    ..There is a marked variation in the frequency of referrals between practices reflecting, in part, inadequate training of general practitioners (GPs) in the management of psoriasis...
  9. ncbi Inpatient management of psoriasis: a multicentre service review to establish national admission standards
    A L Woods
    Skin Therapy Research Unit, St John s Institute of Dermatology, St Thomas Hospital, and Imperial College, London SE1 9RT, UK
    Br J Dermatol 158:266-72. 2008
    ..There is a need for evidence-based national standards for inpatient management of psoriasis taking account of factors that predict length of stay...
  10. ncbi British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005
    C H Smith
    St John's Institute of Dermatology, GKT School of Medicine, St Thomas' Hospital, London SE1 7EH, UK
    Br J Dermatol 153:486-97. 2005
  11. ncbi Contact urticaria due to p-chloro-m-cresol
    S L Walker
    Br J Dermatol 151:936-7. 2004
  12. ncbi Streptococcal infection may make psoriasis worse but do antibiotics help?
    C M Owen
    Br J Dermatol 151:244-5; author reply 245. 2004